Current Award and Grant Recipients
| 2009 Abby S. & Howard P. Milstein Innovation Award For Melanoma/Non-Melanoma Skin Cancer Research | |
 |
Lynda Chin, MD Dana Farber Cancer Institute, Boston Rational therapeutic strategy against braf mutant melanoma |
| 2008 Abby S. & Howard P. Milstein Innovation Award For Melanoma/Non-Melanoma Skin Cancer Research | |
 |
Boris C. Bastian, MD University of California, San Francisco The KIT signaling pathway as a therapeutic target in melanoma |
| 2010 Research Scholars | |
 |
Rizwan Haq, MD, PhD Massachusetts General Hospital Identification and characterization of genetic and chemical approaches to target microphthalmia-associated transcription factor in melanoma |
 |
Roger Lo, MD, PhD University of California, Los Angeles A rational basis to augment v600E B-Raf therapeutic targeting in melanoma |
 |
Kenneth Y. Tsai, MD, PhD MD Anderson Cancer Center, Houston Genetic and cellular determinants of immunosurveillance and immune evasion in skin cancer |
| 2010 Research Grants | |
 |
Joehyuk Choi, MD, PhD Yale University School of Medicine, New Haven A forward genetic screen for tumor suppressor genes using transposon mutagenesis in mouse skin |
 |
Katherine B. Puttgen, MD Johns Hopkins University School of Medicine, Baltimore The role of propranolol in the treatment of function threatening and disfiguring infantile hemangiomas |
 |
Durga Udayakumar, PhD Massachusetts General Hospital, Wellman Center for Photomedicine Elucidating the role of EphA2 in pigment cell biology |
 |
Jonathan Zippin, MD, PhD Weill Cornell Medical Center, New York Soluble adenylyl cyclase is necessary for IL-22-dependnent keratinocyte proliferation |
| 2010 Quality of Life | |
 |
Jean Y. Tang, MD, PhD Stanford University, Redwood City Association of vitamin D levels and basal cell carcinoma risk |
| 2010 Medical Student Grants | |
 |
Yevgeniya Dvorkin Case Western Reserve University, Cleveland Mechanisms of oncogenic transformation of normal melanocytes by ultraviolet radiation and bisphenol A |
 |
Mark Blaine Geyer Columbia University Medical Center, New York Evaluating the incidence, morbidity, mortality and nature of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermoloysis bullosa following allogeneic stem cell transplantation |
 |
Matthew Goldberg Mount Sinai School of Medicine Histone variation and new epigenetic markers of melanoma malignacy |
 |
Elana Shpall Children's Hospital Oakland Research Institute, Oakland UV-induced vitamin D3 production and the risk of basal cell carcinoma carcinogenesis |
 |
Whitney Tolpinrud Yale University Medical School, New Haven Mechanistic elucidation of extracorporeal photochemotherapy, a treatment of cutaneous t cell lymphoma |
